Fulbert Pharmaceuticals Private Limited
About Fulbert Pharmaceuticals Private Limited
Data last updated:
Fulbert Pharmaceuticals Private Limited was a private limited company based in Surat, Gujarat, India. The company has been struck off by the Registrar of Companies, typically due to non-filing of annual returns or failure to commence business. It is no longer operational and cannot enter into any legal contracts or agreements. It operated in the other hospital and medical care activities segment of the healthcare sector. It was incorporated on 09 November 2016.
The company was registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U74999GJ2016PTC094320. The company has 2 GST registrations on record, none of which is active.
The company had an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It was led by directors Rajaram Jamuna Prajapati and Jitendra Prajapati.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office was at 92 Kalyan Kutir Udhna, Surat, Gujarat, India – 394210.
As per the financials filed for FY 2018, the company reported a revenue of ₹5.44 Lakh, a growth of 44% compared to the previous year. For the same year it recorded a net profit of ₹5,381 (net margin 1%) and EBITDA of ₹5,183 (EBITDA margin 1%).
Company details
Contact details
Fulbert Pharmaceuticals Private Limited's registered office is in Surat, Gujarat. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address92 Kalyan Kutir Udhna, Surat, Gujarat, India – 394210
- IndustryHealthcare, Other Hospital And Medical Care Activities
To see the full contact details of Fulbert Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Fulbert Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Fulbert Pharmaceuticals Private Limited, buy the company report.
Financials of Fulbert Pharmaceuticals Private Limited
FY 2018 filings availableFulbert Pharmaceuticals Private Limited reported revenue of ₹5.44 Lakh (up 44% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue rose 44% in the latest year. EBITDA rose 293% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹5,183 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | ₹5,381 | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 1% | |
| Net Profit Margin | 1% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Fulbert Pharmaceuticals Private Limited, buy the company report.
Board of directors of Fulbert Pharmaceuticals Private Limited
Fulbert Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajaram Jamuna Prajapati | Director | 09 Nov 2016 | 9 Years 11 Months | As last reported |
| Jitendra Prajapati | Director | 09 Nov 2016 | 9 Years 11 Months | As last reported |
Auditor
Fulbert Pharmaceuticals Private Limited is audited by G V S D & CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| G V S D & CO | FY 2017 | 021101C |
Shareholding
The shareholding of Fulbert Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Fulbert Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Fulbert Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Fulbert Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Fulbert Pharmaceuticals has 2 GST registrations on record, and all of them have been cancelled or are inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Fulbert Pharmaceuticals Private Limited, buy the company report.
Recent activity
Fulbert Pharmaceuticals Private Limited has 2 board changes on record since 2016: 2 appointments. The latest: Jitendra Prajapati was appointed as Director on 09 Nov 2016.
Frequently asked questions
Fulbert Pharmaceuticals has a status of "Struck Off" as per MCA records. This means the company has been officially removed from the Register of Companies, typically due to non-filing of annual returns or failure to commence business within one year of incorporation. A struck-off company cannot enter into any legal contracts or agreements, and any dealings with such an entity carry significant legal and financial risk.
Fulbert Pharmaceuticals was a private limited company based in Surat, Gujarat, India. The company worked in other hospital and medical care activities, within the healthcare industry. It was incorporated on 09 November 2016 and is registered under CIN U74999GJ2016PTC094320. The company has been struck off by the Registrar of Companies and is no longer operational.
Fulbert Pharmaceuticals had 2 directors:
- Rajaram Jamuna Prajapati - Director
- Jitendra Prajapati - Director
The CIN (Corporate Identification Number) of Fulbert Pharmaceuticals is U74999GJ2016PTC094320. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
The registered office of Fulbert Pharmaceuticals is at 92 Kalyan Kutir Udhna, Surat, Gujarat, India – 394210.
Fulbert Pharmaceuticals was incorporated on 09 November 2016. It is registered with the Registrar of Companies, Ahmedabad.
The latest financial statements of Fulbert Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from FY 2017 are in the company report.
No. Fulbert Pharmaceuticals has 2 GST registrations on record and all of them are cancelled or inactive.
Fulbert Pharmaceuticals operated in the healthcare industry, in the other hospital and medical care activities segment. It worked in this industry before it was struck off.
Jitendra Prajapati was appointed as Director on 09 Nov 2016. Rajaram Jamuna Prajapati was appointed as Director on 09 Nov 2016.